Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mayako Tada"'
Autor:
Yusuke Suzuki, Mayako Tada, Ryuta Enokida, Jiro Takagi, Yoshikazu Araki, Sanjay Pareek, Sanghun Lee, Kohju Ikago, Jia Guo, Kshitij C. Shrestha, Iori Fukuda, Takeshi Masui
Publikováno v:
Frontiers in Built Environment, Vol 10 (2024)
This paper studied the feasibility of a sliding base isolation layer to be used in rubble stone masonry buildings in rural areas in the Himalayan Mountain range to provide robust protection to important building like schools against strong earthquake
Externí odkaz:
https://doaj.org/article/cd5b7c4961434e638e39b33f74e5f3b7
Autor:
Makoto Hirata, Akifumi Matsuyama, Ryuichi Sakate, Ichiro Takahashi, Toru Masui, Yosuke Kameoka, Arihiro Kohara, Mitsuho Sasaki, Mayako Tada
Publikováno v:
Human Cell. 31:183-188
Research on rare diseases cannot be performed without appropriate samples from patients with such diseases. Due to the limited number of such patients, securing biosamples of sufficient quality for extensive research is a challenge and represents an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ec278874d65b87585274fc956700e58
https://doi.org/10.1007/s13577-018-0204-3
https://doi.org/10.1007/s13577-018-0204-3
Publikováno v:
Journal of Translational Science. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67b976c4208fc49c1578f42ed9dfe05f
https://doi.org/10.15761/jts.1000198
https://doi.org/10.15761/jts.1000198
Autor:
Shosuke Okamoto, Yoshio Okada, Yuko Tsuda, Utako Okamoto, Mayako Tada, Keiko Wanaka, Akiko Hijikata-Okunomiya
Publikováno v:
Chemical and Pharmaceutical Bulletin. 49:1457-1463
Based on the structure of Tra-Tyr(O-Pic)-octylamide, a portion of the octylamine was replaced with moieties bearing hydrophobic, basic or acidic groups. Replacement of the C-terminal residue with a moiety bearing a hydrophobic group gave the proper a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d09bf4cbcaefcce78c62766c747aa18f
https://doi.org/10.1248/cpb.49.1457
https://doi.org/10.1248/cpb.49.1457
Autor:
Akiko Hijikata-Okunomiya, Yoshio Okada, Mayako Tada, Atsuko Fukumizu, Keiko Wanaka, Yoko Tsuda, Shosuke Okamoto
Publikováno v:
Chemical and Pharmaceutical Bulletin. 47:1141-1144
Pseudo-peptide analogs of trans-4-aminomethylcyclohexanecarbonyl-L-phenylalanyl-4-aminopheny l acetic acid (PKSI-527, plasma kallikrein selective inhibitor), in which an amide bond (peptide bond) has been replaced by a CH2-NH bond, i.e., trans-4-amin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8baf6ee956cc9e513bc78e82ec816023
https://doi.org/10.1248/cpb.47.1141
https://doi.org/10.1248/cpb.47.1141
Autor:
Yoshio Okada, Shosuke Okamoto, Yuko Tsuda, Utako Okamoto, Mayako Tada, Akiko Hijikata-Okunomiya, Keiko Wanaka
Publikováno v:
Biopolymers. 51:41-50
During the course of the development of active center-directed plasmin inhibitors, it was found that N-(trans-4-aminomethylcyclohexanecarbonyl)-lysine-4-methoxycarbonylanilide inhibited plasma kallikrein more potently than other enzymes such as plasm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::283403b09c2bf7ab1ffb8ef538c761c9
https://doi.org/10.1002/(sici)1097-0282(1999)51:1<41::aid-bip5>3.0.co
https://doi.org/10.1002/(sici)1097-0282(1999)51:1<41::aid-bip5>3.0.co
Autor:
Keiko Wanaka, Yuko Tsuda, Akiko Hijikata-Okunomiya, Noburo Horie, Yoshio Okada, Utako Okamoto, Yukiko Nakaya, Shosuke Okamoto, Mayako Tada
Publikováno v:
Biological and Pharmaceutical Bulletin. 21:105-108
We synthesized a new affinity gel (PKSI-Toyopearl) using a selective synthetic inhibitor of plasma kallikrein (PKSI-527) as an affinity ligand, and employed it for the rapid purification of plasma kallikrein from human plasma. Human plasma activated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca84be359cf3be06f322d420c923d2af
https://doi.org/10.1248/bpb.21.105
https://doi.org/10.1248/bpb.21.105
Autor:
Utako Okamoto, Akiko Hijikata-Okunomiya, Mayako Tada, Shosuke Okamoto, Noboru Horie, Yoshio Okada, Yuko Tsuda, Keiko Wanaka
Publikováno v:
Biologicalpharmaceutical bulletin. 24(5)
We established a simple method for the purification of human plasma kallikrein (PK) by affinity chromatography and characterized it by analytical reverse phase-HPLC and Time of Flight Mass Spectroscopy (TOF-MS). The affinity resin (PKSI-Toyopearl) wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5271f8f92d37d67514b63a196d3078
https://pubmed.ncbi.nlm.nih.gov/11379773
https://pubmed.ncbi.nlm.nih.gov/11379773
Autor:
Yuko Tsuda, Utako Okamoto, Akiko Hijikata-Okunomiya, Shosuke Okamoto, Keiko Wanaka, Mayako Tada, Yoshio Okada
Publikováno v:
Chemicalpharmaceutical bulletin. 48(12)
Based on structure-activity relationship studies, we designed and synthesized plasmin (PL) and plasma kallikrein (PK) inhibitors. Trans-(4-aminomethylcyclohexanecarbonyl)-Tyr(O-Pic)-octylamide inhibited PL, PK, urokinase (UK) and thrombin (TH) with I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::203f3e2c739705cdfd4bbd3211b7c856
https://pubmed.ncbi.nlm.nih.gov/11145152
https://pubmed.ncbi.nlm.nih.gov/11145152
Autor:
Yuko Tsuda, Mayako Tada, oshikazu Matsumoto, Shosuke Okamoto, Akiko Hijikata-Okunomiya, Keiko Wanaka, Yoshio Okada
Publikováno v:
Chemicalpharmaceutical bulletin. 48(2)
Various compounds were synthesized by combining three components at positions P1, P1' and P2'. Of these, N-(trans-4-aminomethylcyclohexanecarbonyl)-Tyr(O-2-bromobenzylo xycarbonyl)- octylamide inhibited plasmin selectively with IC50 values of 0.80 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31718fb8faa290e3b5483f68a1d19348
https://pubmed.ncbi.nlm.nih.gov/10705502
https://pubmed.ncbi.nlm.nih.gov/10705502